TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
330,711
|
299,941
|
206,649 |
| Financial expenses |
431
|
345
|
118 |
| Earnings before taxes |
21,716
|
23,132
|
19,956 |
| EBITDA |
21,284
|
23,345
|
20,107 |
| Total assets |
120,405
|
98,208
|
74,790 |
| Current assets |
119,827
|
97,550
|
74,235 |
| Current liabilities |
46,425
|
36,825
|
31,834 |
| Equity capital |
69,141
|
52,566
|
33,512 |
| - share capital |
106
|
100
|
100 |
| Employees (average) |
227
|
197
|
146 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
57.4%
|
53.5%
|
44.8% |
| Turnover per employee |
1,457
|
1,523
|
1,415 |
| Profit as a percentage of turnover |
6.6%
|
7.7%
|
9.7% |
| Return on assets (ROA) |
18.4%
|
23.9%
|
26.8% |
| Current ratio |
258.1%
|
264.9%
|
233.2% |
| Return on equity (ROE) |
31.4%
|
44.0%
|
59.5% |
| Change turnover |
30,770
|
93,292
|
48,114 |
| Change turnover % |
10%
|
45%
|
30% |
| Chg. No. of employees |
30
|
51
|
34 |
| Chg. No. of employees % |
15%
|
35%
|
30% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.